Literature DB >> 15753310

Implications of an antiparallel dimeric structure of nonphosphorylated STAT1 for the activation-inactivation cycle.

Minghao Zhong1, Melissa A Henriksen, Kenji Takeuchi, Olaf Schaefer, Bin Liu, Johanna ten Hoeve, Zhiyong Ren, Xiang Mao, Xiaomin Chen, Ke Shuai, James E Darnell.   

Abstract

IFN-gamma treatment of cells leads to tyrosine phosphorylation of signal transducer and activator of transcription (STAT) 1 followed by dimerization through a reciprocal Src homology 2-phosphotyrosine interaction near the -COOH end of each monomer, forming a parallel structure that accumulates in the nucleus to drive transcription. Prompt dephosphorylation and return to the cytoplasm completes the activation-inactivation cycle. Nonphosphorylated STATs dimerize, and a previously described interface between N-terminal domain (ND) dimers has been implicated in this dimerization. A new crystal structure of nonphosphorylated STAT1 containing the ND dimer has two possible configurations for the body of STAT1, one of which is antiparallel. In this antiparallel structure, the Src homology 2 domains are at opposite ends of the dimer, with the coiled:coil domain of one monomer interacting reciprocally with the DNA-binding domain of its partner. Here, we find that mutations in either the coiled:coil/DNA-binding domain interface or the ND dimer interface block dimerization of nonphosphorylated molecules and cause a resistance to dephosphorylation in vivo and resistance to a tyrosine phosphatase in vitro. We conclude that a parallel STAT1 phosphodimer not bound to DNA most likely undergoes a conformational rearrangement (parallel to antiparallel) to present the phosphotyrosine efficiently for dephosphorylation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15753310      PMCID: PMC554839          DOI: 10.1073/pnas.0501063102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Nuclear export signal located within theDNA-binding domain of the STAT1transcription factor.

Authors:  K M McBride; C McDonald; N C Reich
Journal:  EMBO J       Date:  2000-11-15       Impact factor: 11.598

2.  A reinterpretation of the dimerization interface of the N-terminal domains of STATs.

Authors:  Xiaomin Chen; Rashna Bhandari; Uwe Vinkemeier; Focco Van Den Akker; James E Darnell; John Kuriyan
Journal:  Protein Sci       Date:  2003-02       Impact factor: 6.725

3.  STATs dimerize in the absence of phosphorylation.

Authors:  Jutta Braunstein; Siska Brutsaert; Rich Olson; Christian Schindler
Journal:  J Biol Chem       Date:  2003-06-28       Impact factor: 5.157

4.  DNA binding controls inactivation and nuclear accumulation of the transcription factor Stat1.

Authors:  Thomas Meyer; Andreas Marg; Petra Lemke; Burkhard Wiesner; Uwe Vinkemeier
Journal:  Genes Dev       Date:  2003-08-15       Impact factor: 11.361

5.  Roles of activated Src and Stat3 signaling in melanoma tumor cell growth.

Authors:  Guilian Niu; Tammy Bowman; Mei Huang; Steve Shivers; Douglas Reintgen; Adil Daud; Alfred Chang; Alan Kraker; Richard Jove; Hua Yu
Journal:  Oncogene       Date:  2002-10-10       Impact factor: 9.867

6.  Arginine/lysine-rich nuclear localization signals mediate interactions between dimeric STATs and importin alpha 5.

Authors:  Riku Fagerlund; Krister Mélen; Leena Kinnunen; Ilkka Julkunen
Journal:  J Biol Chem       Date:  2002-06-04       Impact factor: 5.157

7.  Structure of an activated Dictyostelium STAT in its DNA-unbound form.

Authors:  Montserrat Soler-Lopez; Carlo Petosa; Masashi Fukuzawa; Raimond Ravelli; Jeffrey G Williams; Christoph W Müller
Journal:  Mol Cell       Date:  2004-03-26       Impact factor: 17.970

8.  N-domain-dependent nonphosphorylated STAT4 dimers required for cytokine-driven activation.

Authors:  Naruhisa Ota; Tom J Brett; Theresa L Murphy; Daved H Fremont; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2004-01-04       Impact factor: 25.606

9.  Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway.

Authors:  M A Meraz; J M White; K C Sheehan; E A Bach; S J Rodig; A S Dighe; D H Kaplan; J K Riley; A C Greenlund; D Campbell; K Carver-Moore; R N DuBois; R Clark; M Aguet; R D Schreiber
Journal:  Cell       Date:  1996-02-09       Impact factor: 41.582

10.  Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions.

Authors:  K Shuai; C M Horvath; L H Huang; S A Qureshi; D Cowburn; J E Darnell
Journal:  Cell       Date:  1994-03-11       Impact factor: 41.582

View more
  71 in total

1.  STAT3 Inhibition Induces Apoptosis in Cancer Cells Independent of STAT1 or STAT2.

Authors:  Adetola Shodeinde; Kalyani Ginjupalli; H Dan Lewis; Sheraz Riaz; Beverly E Barton
Journal:  J Mol Biochem       Date:  2013-02-20

Review 2.  Biology and significance of the JAK/STAT signalling pathways.

Authors:  Hiu Kiu; Sandra E Nicholson
Journal:  Growth Factors       Date:  2012-02-20       Impact factor: 2.511

3.  Characterization of a dominant-active STAT that promotes tumorigenesis in Drosophila.

Authors:  Laura A Ekas; Timothy J Cardozo; Maria Sol Flaherty; Elizabeth A McMillan; Foster C Gonsalves; Erika A Bach
Journal:  Dev Biol       Date:  2010-05-23       Impact factor: 3.582

Review 4.  STAT signaling in polycystic kidney disease.

Authors:  Sebastian Strubl; Jacob A Torres; Alison K Spindt; Hannah Pellegrini; Max C Liebau; Thomas Weimbs
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

5.  Dephosphorylation of phosphotyrosine on STAT1 dimers requires extensive spatial reorientation of the monomers facilitated by the N-terminal domain.

Authors:  Claudia Mertens; Minghao Zhong; Ravi Krishnaraj; Wenxin Zou; Xiaomin Chen; James E Darnell
Journal:  Genes Dev       Date:  2006-12-15       Impact factor: 11.361

6.  Dimeric quaternary structure of the prototypical dual specificity phosphatase VH1.

Authors:  Adem C Koksal; Jonathan D Nardozzi; Gino Cingolani
Journal:  J Biol Chem       Date:  2009-02-10       Impact factor: 5.157

7.  A phosphorylation-acetylation switch regulates STAT1 signaling.

Authors:  Oliver H Krämer; Shirley K Knauer; Georg Greiner; Enrico Jandt; Sigrid Reichardt; Karl-Heinz Gührs; Roland H Stauber; Frank D Böhmer; Thorsten Heinzel
Journal:  Genes Dev       Date:  2009-01-15       Impact factor: 11.361

8.  Serpin B3/B4, activated by STAT3, promote survival of squamous carcinoma cells.

Authors:  Simi T Ahmed; James E Darnell
Journal:  Biochem Biophys Res Commun       Date:  2008-12-12       Impact factor: 3.575

9.  Wedelolactone, a naturally occurring coumestan, enhances interferon-γ signaling through inhibiting STAT1 protein dephosphorylation.

Authors:  Zhimin Chen; Xiaoxiao Sun; Shensi Shen; Haohao Zhang; Xiuquan Ma; Jingli Liu; Shan Kuang; Qiang Yu
Journal:  J Biol Chem       Date:  2013-04-11       Impact factor: 5.157

10.  STAT3 inhibition in prostate and pancreatic cancer lines by STAT3 binding sequence oligonucleotides: differential activity between 5' and 3' ends.

Authors:  H Dan Lewis; Ashley Winter; Thomas F Murphy; Snehlata Tripathi; Virendra N Pandey; Beverly E Barton
Journal:  Mol Cancer Ther       Date:  2008-06       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.